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UVR-Induced Regulatory T Cells Switch
Antigen-Presenting Cells from a Stimulatory to a
Regulatory Phenotype
Agatha Schwarz1 and Thomas Schwarz1
UVR-induced regulatory T cells (UVR-Treg) inhibit sensitization in an antigen-specific manner. The migratory
behavior of UVR-Treg can be reprogrammed by antigen-presenting cells (APCs), indicating a cross-talk between
these cells. Hence, we sought to investigate whether in turn UVR-Treg can influence APCs. Bone marrow–
derived dendritic cells (DCs) were co-incubated with DNFB-specific UVR-Treg. DCs were isolated, coupled with
DNBS, and injected into naive mice. Contrary to untreated dinitrobenzenesulfonic acid (DNBS)-coupled DC,
DCs from the cocultures failed to induce sensitization in the recipients. Antibody blocking and transwell
experiments indicated that both IL-10 and cellular contact are required during the co-incubation to induce
inhibition. UVR-Treg downregulated B7-2 and major histocompatibility complex class II but induced the
negative regulatory molecules B7-H3 and B7-H4 on DC. To suppress, UVR-Treg had to be activated in an antigen-
specific manner. However, the suppression was not antigen-specific as activated DNFB-specific UVR-Treg
inhibited DCs to sensitize also against trinitrochlorobenzene. Adoptive transfer experiments revealed that
injection of hapten-coupled DCs, which were co-incubated with UVR-Treg, further induced Treg in the
recipients. Together, this indicates that activated UVR-Treg can alter APCs in such a way that they lose their
sensitizing capacity but in turn induce Treg. Thus, UVR-Tregs switch APCs from a stimulatory to a regulatory
phenotype.
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INTRODUCTION
UVR, in particular UVB, exerts immunosuppressive proper-
ties, which is shown by the inhibition of cellular immune
reactions, such as contact hypersensitivity (CHS) (Toews
et al., 1980). UVR inhibits the sensitization to contact
allergens when they are applied onto UVR-exposed skin.
The very same individuals cannot be sensitized against the
same hapten later, although other immune reactions are not
suppressed, indicating hapten-specific tolerance. This un-
responsiveness can be adoptively transferred by injection of
lymph node cells obtained from UVR-tolerized mice into
naive recipients that subsequently cannot be sensitized
against the respective hapten (Elmets et al., 1983). This
indicated that UVR-induced tolerance is mediated through
the induction of hapten-specific T suppressor cells, nowadays
called regulatory T cells (Treg) (Beissert et al., 2006).
UVR-induced Tregs (UVR-Tregs) suppressing CHS are
quite well characterized. They express CD4 and CD25
(Schwarz et al., 2004), CTLA-4 (Schwarz et al., 2000),
glucocorticoid-induced tumor necrosis factor receptor
(Maeda et al., 2008), and secrete IL-10 on hapten-specific
stimulation. The induction of Treg by UVR appears to be
critically dependent on the migration of Langerhans cells into
the lymph nodes and the presence of UVR-induced DNA
damage in these cells (Schwarz et al., 2005) as IL-12, which
reduces DNA damage (Schwarz et al., 2002), prevents the
generation of UVR-Treg.
When injected intravenously (i.v.), UVR-Treg migrate
into lymph nodes because they express the lymph node
homing receptor CD62L (Schwarz et al., 2004). We observed
that on incubation with antigen-presenting cells (APCs)
derived from the epidermis UVR-Treg downregulate CD62L
but express the ligands for the skin homing receptors
(Schwarz et al., 2007). In contrast, when incubated with
dendritic cells (DCs) derived from lymphoid organs, UVR-
Treg still migrated into the lymph nodes. This indicated
that the migratory behavior of UVR-Treg can be influenced
by tissue-specific DCs, which might have important
implications on strategies trying to use UVR-Treg therpeuti-
cally. On the basis of the observation that DC can
modulate UVR-Treg, we asked whether UVR-Treg in turn
can influence DC.
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RESULTS
DC lose their sensitizing capacity after co-incubation with
UVR-Treg
Dendritic cells were obtained from bone marrow. UVR-Tregs
were induced by painting DNFB on the backs of mice that
had been exposed to UVR (1.2 kJm2) on 4 consecutive days.
At 5 days after DNFB application lymph node cells and
splenocytes were obtained. CD4þCD25þ cells were isolated
by magnetobead separation and incubated with DC (ratio
2:1). To activate these UVR-Tregs, which are specific for
DNFB, DCs were coupled for 30minutes with DNBS and
after washing were mixed with the CD4þCD25þ cells. After
incubation for 16 hours T cells were depleted by magneto-
bead separation with an anti-CD3 antibody. After washing
the remaining fraction, representing the incubated DC, were
coupled with DNBS. Cells (7105) were injected s.c. into
naive mice. After 5 days, challenge with DNFB was
performed on the left ear and ear swelling was measured
24 hours later. Mice that were injected with uncoupled DC
did not reveal an ear swelling response (no. 2), whereas mice
injected with DNBS-coupled DC (no. 1) responded with
pronounced swelling (Figure 1a), indicating sensitization
against DNFB. In contrast, mice injected with DNBS-coupled
DCs that were co-incubated with UVR-Treg did not reveal a
swelling response on DNFB challenge (no. 3). This indicates
that DCs had lost their sensitizing capacity on incubation
with UVR-Treg.
To prove that this effect is specific for UVR-Treg, we
repeated the experiment mentioned above. In addition, DCs
were incubated in the presence of DNBS with CD4þCD25
T cells obtained from UVR-tolerized mice. DCs incubated
with CD4þCD25þ T cells failed to induce sensitization on
s.c. injection (no. 3, Figure 1b), confirming the data shown in
Figure 1a. DNBS-coupled DCs that were incubated with
CD4þCD25 T cells were not impaired in their sensitizing
capacity (no. 4), indicated by the pronounced CHS response
of the recipients.
When DCs were incubated in the presence of DNBS with
CD4þCD25þ T cells obtained from naive donors, they
retained their sensitizing capacity. DCs were obtained from
these cocultures and coupled with DNBS-sensitized naive
mice when injected s.c. (no. 3, Figure 2a). Likewise, DC
function was not affected on co-incubation with
CD4þCD25 T cells from naive donors (no. 4).
To address the antigen specificity, we next tested whether
UVR-Tregs have to be activated in an antigen-specific
manner to exert their suppressive effect on DCs and whether
the suppression itself is antigen specific. For that purpose
2,4,6-trinitrochlorobenzene (TNCB) and its water-soluble
analogue trinitrobenzenesulfonic acid (TNBS) were used.
DNFB-specific UVR-Treg were incubated with TNBS-pulsed
DC. After 16 hours DC were isolated, pulsed again with
TNBS, and injected s.c. into naive mice. Untreated DCs
coupled with TNBS (no. 1) and injected as a positive control
induced a pronounced ear swelling response on challenge
with TNCB, indicating successful sensitization against TNCB
(Figure 2b). Injection of DCs, which were preincubated with
DNFB-specific UVR-Treg but, in contrast to the previous
experiment, in the absence of DNBS and in the presence of
TNBS, induced an ear swelling response (no. 3) comparable
to that of the positive control. This indicates that despite the
co-incubation with UVR-Treg, DCs retained their sensitizing
capacity. Because in this experiment TNBS and not DNBS
was present during the incubation, UVR-Tregs, which are
specific for DNFB, were not activated.
In the fourth group in Figure 2b, UVR-Tregs were co-
incubated with DNBS-coupled DC to activate UVR-Tregs.
After 16 hours DC were isolated, washed, coupled with
TNBS, and injected s.c. into naive mice. In this case,
recipients revealed a significantly reduced ear swelling
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Figure 1. UVR-Tregs inhibit DCs. (a) DNBS-pulsed DCs were cocultured with
CD4þCD25þ Tregs obtained from UVR-tolerized donors (no. 3). After
16 hours DC were isolated, coupled with DNBS, and injected s.c. into naive
mice. After 5 days DNFB challenge was performed, ear swelling was
measured after 24 hours. Positive controls (no. 1) were sensitized by s.c.
injection of DNBS-coupled DCs followed by DNFB challenge. Negative
controls (no. 2) were injected with uncoupled DCs. Ear swelling is expressed
as the difference between the thickness of the challenged and the vehicle-
treated ear. *Po0.005 vs. Neg Co; **Po 0.0005 vs. Pos Co. (b) DNBS-pulsed
DCs were cocultured either with CD4þCD25þ (no. 3) or with CD4þCD25
cells (no. 4) that were obtained from UVR-tolerized donors. Otherwise, the
experiment was performed identically as in a. *Po0.00001 vs. Pos Co;
**Po0.0001 vs DCþCD4þCD25þ . DC, dendritic cell; DNBS,
dinitrobenzenesulfonic acid; UVR-Treg, UVR-induced regulatory T cell.
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response to TNCB in comparison with positive controls
(no. 1). This suggests that the suppression induced by UVR-Treg,
once activated in an antigen-specific manner, is nonspecific.
UVR-Treg inhibit APC through IL-10
UVR-Treg exert their suppressive activity, at least in part,
through IL-10 (Schwarz et al., 2004). To determine whether
the inhibition of APC by UVR-Treg is also mediated through
IL-10, we performed antibody blocking. UVR-Treg were co-
incubated with DNBS-pulsed DC for 16 hours. To one
incubation group (no. 4, Figure 3a) an IL-10 antibody was
added (15 mgml1). DCs were isolated, pulsed with TNBS,
and injected s.c. into naive mice. Recipients were challenged
with TNCB 5 days later. Mice injected with DCs coupled
with TNBS but first incubated with UVR-Treg did not
react with ear swelling on challenge (no. 3, Figure 3a). In
contrast mice injected with DC, which were treated
identically as those in group 3 but in addition were exposed
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Figure 2. UVR-Treg-activated antigen specifically inhibit DCs in a
nonspecific manner. (a) TNBS-pulsed DCs were cocultured with
CD4þCD25þ (no. 3) or CD4þCD25 (no. 4) cells from naive donors. After
16 hours T cells were depleted, DCs were coupled with TNBS and injected
s.c. into naive mice. After 5 days ear challenge with TNCB was performed and
ear swelling was measured. Positive controls (no. 1) were sensitized by s.c.
injection of TNBS-coupled DCs followed by TNCB challenge 5 days later.
Negative controls (no. 2) were injected with uncoupled DCs followed by
TNCB challenge. Ear swelling is expressed as the difference between the
thickness of the challenged and of the vehicle-treated ear. NS (not significant)
vs Pos Co. (b) DCs pulsed with TNBS (no. 3) or DNBS (no. 4) were cocultured
with UVR-Treg (DNFB specific) for 16 hours. After depletion of T cells, DCs
were pulsed with TNBS and injected s.c. into naive mice. After 5 days ears
were challenged with TNCB. Positive controls (no. 1) were injected with
untreated TNBS-coupled DCs and challenged with TNCB 5 days later.
Negative controls were challenged with TNCB only (no. 2). *Po0.001 vs
UVR-TregþDNBS; **Po 0.000001 vs Pos Co. DC, dendritic cell; DNBS,
dinitrobenzenesulfonic acid; TNBS, trinitrobenzenesulfonic acid; TNCB,
2,4,6-trinitrochlorobenzene; UVR-Treg, UVR-induced regulatory T cell.
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Figure 3. Inhibition is mediated through IL-10. (a) DNBS-pulsed DCs were
cocultured with UVR-Tregs in the absence (no. 3) or presence of an IL-10-
antibody (no. 4). T cells were depleted, DCs were pulsed with TNBS and
injected s.c. into naive mice. After 5 days, ears were challenged with TNCB
and ear swelling was measured. Positive controls (no. 1) were injected with
untreated TNBS-coupled DCs. Negative controls were ear challenged only
(no. 2). Ear swelling is expressed as the difference between the thickness of
the challenged and that of the vehicle-treated ear. *Po0.00005 vs Pos. Co.;
**Po0.02 vs UVR-Treg. (b) DCs from IL-10 knockout mice were cocultured
with DNBS and UVR-Tregs were obtained from wild-type mice. DCs were
isolated, pulsed with DNBS, and injected s.c. into naive wild-type mice
(no. 3). After 5 days ears were challenged with DNFB and swelling was
measured 24 hours later. Positive controls were wild-type mice sensitized by
s.c. injection of DNBS-coupled DCs obtained from IL-10 knockout followed
by ear challenge with DNFB 5 days later (no. 1). Negative controls were wild-
type mice that were challenged with DNFB only (no. 2). *Po 0.01 vs Pos.
Co. DC, dendritic cell; DNBS, dinitrobenzenesulfonic acid; TNBS,
trinitrobenzenesulfonic acid; TNCB, 2,4,6-trinitrochlorobenzene; UVR-Treg,
UVR-induced regulatory T cell.
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to the IL-10 antibody, responded with an ear swelling
response on challenge (no. 4) comparable to that of positive
controls (no. 1). This implies that the inhibition is mediated
through IL-10.
To discern whether DCs or UVR-Tregs are the primary
source of IL-10, we obtained DCs from IL-10-deficient
mice. One group of DNBS-pulsed DC was incubated with
UVR-Treg obtained from wild-type mice. After 16 hours DC
were isolated, coupled with DNBS, and injected into
naive wild-type mice. Recipients were challenged with
DNFB 5 days later. Injection of DCs from IL-10-deficient
mice that were coupled with DNBS induced sensitization
of naive mice (no. 1), as shown by the specific ear swelling
response in comparison to negative control mice (no. 2)
that were injected with uncoupled DCs (Figure 3b). Mice
injected with DNBS-coupled IL-10-deficient DCs that were
incubated with UVR-Treg did not reveal a specific ear
swelling response on challenge (no. 3). Because the suppres-
sion is still observed when using DCs from IL-10-deficient
mice, IL-10 is not derived from the DCs but rather from the
UVR-Tregs.
Cell contact is required for inhibition
The observation that the suppression is mediated through
IL-10 does not exclude that cell-to-cell contact between APC
and UVR-Treg is required. Thus, transwell experiments were
performed. UVR-Tregs were incubated with DNBS-coupled
DC. In parallel UVR-Tregs and DNBS-coupled DCs were
incubated in separate transwell chambers. After incubation
for 16 hours, DCs were isolated and coupled with TNBS.
Cells were injected s.c. into naive mice. On injection of DC
incubated together with UVR-Treg, recipient mice did not
respond with ear swelling on challenge with TNCB (Figure 4,
no. 3). In contrast when TNBS-coupled DCs from the
transwell chambers were injected into naive mice (no. 4),
the recipients revealed an ear swelling response on TNCB
challenge comparable to positive control mice that were
injected with TNBS-coupled DCs (no. 1). This indicates that
UVR-Tregs require cellular contact with the DCs to exert their
suppressive activity.
Alteration of surface molecule expression on DC by UV-Treg
Expression of surface molecules on DCs is critical for antigen
presentation (Crow, 2006). Hence FACS analysis was
performed. DNBS-coupled DCs were cocultured with UVR-
Tregs, isolated after 16 hours, and were subjected to FACS
analysis. DCs, which were not co-incubated with UVR-Treg
but treated otherwise identically, were included as a positive
control, unstained DCs as a negative control. Untreated DCs
revealed strong expression of major histocompatibility com-
plex (MHC) class II and B7-2 (Figure 5a). The expression
of both surface markers was reduced on incubation with
UVR-Treg.
B7-H3 and B7-H4 belong to the B7 family and exert
negative regulatory function (Boenisch et al., 2008). Un-
treated DCs revealed weak expression of B7-H3 and B7-H4
(Figure 5b). On incubation with DNFB-specific UVR-Tregs in
the presence of DNBS, both markers were induced.
DCs preincubated with UVR-Tregs further induce Tregs
Because of the altered phenotype of DC induced by UVR-
Treg, we were interested to determine whether these DCs are
able to induce Tregs. DNBS-pulsed DCs were co-incubated
with UVR-Treg in the absence or presence of an anti-IL-10
antibody. After 16 hours, DCs were isolated, coupled with
TNBS, and injected s.c. into naive mice. After 5 days, lymph
nodes and splenocytes were obtained from these recipients
and T cells were isolated. T cells (5107) were adoptively
transferred i.v. into naive mice. Recipients were sensitized
after 24 hours against TNCB and challenged 5 days later.
Mice that had received T cells from donors injected with DCs
preincubated with UVR-Treg in the presence of the IL-10
antibody revealed an ear swelling response (no. 4, Figure 6a)
comparable to that of positive control mice (no. 1). In
contrast, ear swelling was reduced in those mice (no. 3) that
had received T cells obtained from donors injected with DCs
preincubated with activated UVR-Treg in the absence of the
IL-10 antibody. Because in this setting the ear swelling
response was suppressed, this implies that Treg were induced
in the respective donors and adoptively transferred into the
recipients.
To prove that the suppression by the adoptive transfer is
due to CD4þCD25þ Tregs induced in the recipients of
co-incubated DCs, we repeated the experiment. This time
T cells were separated into CD4þCD25þ and CD4þCD25
before adoptive transfer. Mice receiving only CD4þCD25þ
but not CD4þCD25 were suppressed in their CHS response
(Figure 6b).
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Figure 4. Inhibition of DCs by UVR-Tregs is cell contact dependent. DNBS-
pulsed DCs were cocultured with UVR-Tregs for 16 hours (no. 3). In one
co-incubation DCs and UV-Tregs were separated by transwell chambers
(no. 4). DCs were isolated, pulsed with TNBS, and injected s.c. into naive
mice. After 5 days, ears were challenged with TNCB. Ear swelling was
measured 24 hours later. Positive controls (no. 1) were injected with untreated
DCs coupled with TNBS. Negative controls were challenged only (no. 2).
Ear swelling is expressed as the difference between the thickness of the
challenged and that of the vehicle-treated ear. *Po0.0001 vs Pos Co;
NS (not significant) vs Pos Co. DC, dendritic cell; DNBS,
dinitrobenzenesulfonic acid; TNBS, trinitrobenzenesulfonic acid; TNCB,
2,4,6-trinitrochlorobenzene; UVR-Treg, UVR-induced regulatory T cell.
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DISCUSSION
Regulatory T cells comprise a subset of T cells that mediate
peripheral tolerance. There are two types of Tregs, natural
Tregs, developing in the thymus, and induced Tregs,
developing in the periphery (Workman et al., 2009). Natural
Treg are characterized by the expression of CD4, CD25,
CTLA-4, CD62L, CD103, glucocorticoid-induced tumor
necrosis factor receptor, neuropilin, CD152, CD103, and
the transcription factor Foxp3 (Sakaguchi et al., 2008). The
induced Tregs develop in the periphery from mature T cells
that are activated under suboptimal conditions such as low
antigen exposure, absence of co-stimulatory molecules, or
presence of inhibitory cytokines (Kabelitz et al., 2006).
Tregs induced by UVR share most of the characteristics of
CD4þCD25þ Tregs but their inhibitory capacity is crucially
dependent on IL-10 (Schwarz et al., 2004). In addition, UVR-
Tregs suppress sensitization in an antigen-specific manner. In
the present study we exclusively used DNFB-specific Tregs
that were induced by the application of DNFB onto UVR-
exposed skin. The antigen specificity, however, appears to be
restricted to the activation of UVR-Tregs and not to the
suppressive activity itself, as once activated antigen specifically,
they release IL-10 and thereby suppress also other immune
reactions, as it has been described for bystander suppression
(Groux and Powrie, 1999; Schwarz et al., 2004).
Because DCs can influence the behavior of UVR-Tregs
(Schwarz et al., 2007), we asked whether in turn UVR-Tregs
can influence DCs. This question was also inspired by
previous observations that naturally occurring Tregs are able
to affect DC development, preventing maturation and
inducing IL-10 as well as negative regulatory molecules of
the B7 family on DCs (Misra et al., 2004; Kryczek et al.,
2006; Veldhoen et al., 2006; Mahnke et al., 2007a). Besides
the question whether the same applies for UVR-Treg we were
in particular interested whether UVR-Tregs may inhibit DCs
also antigen specifically.
Upon co-incubation with UVR-Tregs, DCs were no longer
able to sensitize when coupled with a hapten and injected
s.c. into naive mice. UVR-Tregs, however, exert this
suppressive activity only when they are activated in an
antigen-specific manner during the incubation as they act
suppressive only in the presence of the specific hapten
DNBS. Addition of TNBS did not activate the UVR-Tregs,
which are specific for DNFB. However, once activated
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Figure 5. Modulation of surface molecule expression on DCs by UVR-Tregs. DCs were cocultured with UVR-Treg in the presence of DNBS (DCþUVR-Treg).
After 16 hours DCs were isolated and subjected to FACS analysis using antibodies against major histocompatibility complex (MHC II) and B7-2 (a) as well as
against B7-H3 and B7-H4. (b) Unstained DCs were included as negative controls, untreated DCs stained with the respective antibodies as positive controls (DC).
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regulatory T cell.
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antigen specifically UVR-Tregs suppress in an antigen-
independent manner. This is concluded from the observation
that DCs that were co-incubated with activated DNFB-
specific UVR-Tregs were not only suppressed their sensitizing
capacity against DNFB but also against TNCB.
This might be explained by the release of IL-10, as
addition of an IL-10 antibody prevented the inhibition of DC
by UVR-Treg. Several studies have shown that natural Tregs
trigger high levels of IL-10 production by DCs (Misra et al.,
2004; Kryczek et al., 2006). In this respect UVR-Tregs seem
to differ from natural Tregs. In our coculture experiments
IL-10 does not appear to be derived from DC as the inhibitory
effect was still observed in DC from IL-10-deficient mice.
Hence, UVR-Tregs are the likely source for IL-10. The reverse
experiment using UVR-Tregs from IL-10-deficient mice and
co-incubating those with wild-type DCs was not performed
as IL-10 appears to be required for the development of UVR-
Tregs. Despite the crucial role of IL-10, UVR-Tregs have to
have cell contact with DCs to exert their suppressive activity
as inhibition was lost in transwell experiments. One
explanation for this phenomenon is the requirement of
UVR-Tregs to get activated by DCs in an antigen-specific
manner to release IL-10.
The loss of the sensitizing capacity by DCs may be
associated with an alteration in the expression of surface
molecules. DCs isolated after the co-incubation with UVR-
Treg expressed lower amounts of MHC class II and B7-2
molecules. This could be mediated through IL-10 that was
found to downregulate MHC class II (de Waal Malefyt et al.,
1991) and B7-2 (Steinbrink et al., 1997). In contrast, the
negative regulatory molecules B7-H3 and B7-H4 were
induced on incubation with UVR-Tregs. Induction of B7-H4
on APC by natural Treg has been described (Kryczek et al.,
2006). This induction appeared to be mediated through DC-
derived IL-10. In addition, upregulation of B7-H3 on DC cells
by natural Treg was observed (Mahnke et al., 2007a). It will
be determined in the future whether this upregulation is
functionally relevant by using blocking antibodies.
It has been reported that natural Tregs form aggregates
with DC in a LFA-1-dependent manner (Onishi et al., 2008)
and downregulate B7-1 and B7-2 but not MHC class II on
DCs (Wing et al., 2008). This downregulation appears to be
critically dependent on CTLA-4 as Tregs lacking the expres-
sion of CTLA-4 do not exert this effect. UVR-Tregs also
express CTLA-4 and this appears to be functionally relevant
(Schwarz et al., 2000). It remains to be determined whether
the modulation of surface molecule expression on DC on co-
incubation with UVR-Tregs is dependent on the expression of
CTLA-4 or exclusively mediated through IL-10.
There is evidence that natural Tregs inhibit the antigen-
presenting capacity of DC (Misra et al., 2004; Kryczek et al.,
2006; Veldhoen et al., 2006) and we show here that this
applies also for UVR-Tregs. A feedback loop has been
postulated, suggesting that Treg-modified DCs, which exert
an immature phenotype, may even induce more Tregs
(Mahnke et al., 2007b). However, this has not been proven
so far. Therefore we studied whether DCs modified by UVR-
Treg in turn can induce Tregs. Adoptive transfer experiments
showed that i.v. injection of T cells derived from donor mice
that were injected with DCs modified by UVR-Treg inhibited
the sensitization of naive recipients. This indicates that Tregs
have developed in mice injected with DCs that were
preincubated with UVR-Tregs. The transferred Tregs appear
to belong to the CD4þCD25þ subtype as on depletion of
CD4þCD25þ cells transfer was lost. In turn, injection of
CD4þCD25þ cells caused suppression. It may be surprising
that the suppression on injection of bulk cells (Figure 6a)
appeared to be more pronounced than on injection of
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Figure 6. DCs modified by UVR-Tregs further induce Tregs. (a) DNBS-pulsed
DCs and UVR-Tregs were co-incubated in the absence (no. 3) or presence of
an IL-10 antibody (no. 4). After 16 hours DCs were isolated, coupled with
TNBS, and injected s.c. into naive mice. After 5 days, T cells were obtained
from the recipients and injected i.v. into naive mice (nos. 3 and 4). After
24 hours these recipients were sensitized against TNCB, and after 5 days ears
were challenged with TNCB. Positive controls were TNCB-sensitized and
challenged (no. 1), negative controls were ear challenged only (no. 2). Ear
swelling is expressed as the difference between the thickness of the
challenged and of the vehicle-treated ear. *Po0.05 vs Pos Co; **Po0.005 vs
UVR-Treg. (b) Cells from lymph nodes and spleens from mice that were
injected with DNBS-coupled DCs after co-incubation with CD4þCD25þ
cells. Cells were separated into CD4þCD25þ and CD4þCD25 cells and
injected i.v. into naive mice (nos. 3 and 4). Recipients were DNFB-sensitized
24hours later. After 5 days ears were challenged. Positive controls were
sensitized and challenged with DNFB (no. 1), negative controls were ear
challenged only (no. 2). Ear swelling is expressed as the difference between
the thickness of the challenged and of the vehicle-treated ear. *Po0.0005 vs
Pos Co; **Po0.005 vs CD4þCD25þ . DC, dendritic cell; DNBS,
dinitrobenzenesulfonic acid; TNBS, trinitrobenzenesulfonic acid; TNCB,
2,4,6-trinitrochlorobenzene; UVR-Treg, UVR-induced regulatory T cell.
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purified CD4þCD25þ cells (Figure 6b). However, one has to
take into account that probably not all CD4þCD25þ cells
mediate hapten-specific suppression but only a small fraction
within this population. Unfortunately, no specific marker for
these cells is available. Thus, further phenotypic character-
ization of these cells will remain one of the major future
challenges.
Together, the data imply that UVR-Tregs exert the capacity
not only to downregulate immune responses but also to
stabilize this downregulation by further inducing Tregs. The
latter effect appears to be mediated by the capacity of UVR-
Tregs to switch the phenotype of DCs from a stimulatory into
a regulatory one.
MATERIALS AND METHODS
Animals
C57BL/6 and IL-10-deficient mice were purchased
from Charles River Laboratories (Sulzfeld, Germany).
Animals were housed under specific pathogen-free condi-
tions. Animal care was provided by expert personnel in
compliance with the relevant laws and institutional guide-
lines. DNFB, DNBS, TNCB, and TNBS were obtained from
Sigma-Aldrich (St Louis, MO). An antibody-neutralizing
murine IL-10 was purchased from R&D Systems (Wiesbaden,
Germany).
Contact hypersensitivity
Mice were sensitized by painting 50 ml DNFB solution (0.5%
in acetone/olive oil, 4:1) on the shaved back on day 0. On
day 5, 20ml 0.3% DNFB was applied on the left ear. Ear
swelling was quantified with a spring-loaded micrometer
24 hours later. CHS was determined as the amount of
swelling of the hapten-challenged ear compared with the
thickness of the vehicle-treated ear and expressed in
cm103 (mean±SD). Each group consisted of at least
seven mice. Each experiment was performed at least two
times. For sensitization against TNCB 25 ml of a 1% solution
was used, for challenge 20 ml of a 0.5% solution was used.
For sensitization by injection with hapten-coupled APC,
DCs were coupled with DNBS or TNBS (1mM each) for
30minutes. After washing 7105 cells were injected s.c. into
the back of naive mice. Challenge with either DNFB or TNCB
was performed 5 days later on the left ear.
Generation of UVR-Tregs
Mice were exposed on their shaved backs to UVR (1.2 kJm2;
TL12 fluorescent lamps; Philips, Eindhoven, the Netherlands)
daily for 4 consecutive days. At 24 hours after the last
exposure mice DNFB was painted onto UVR-exposed skin.
After 5 days, spleens and regional lymph nodes were
removed and single cell suspensions were prepared.
CD4þCD25þ Tregs were isolated in a two-step procedure,
according to the protocol of a magnetic separation kit
(CD4þCD25þ Regulatory T Cell Isolation Kit; Miltenyi
Biotec, Bergisch Gladbach, Germany).
For adoptive transfer, T cells were obtained from lymph
nodes and spleens from donor mice. Cells (5 107) were
injected i.v. into naive mice. Recipients were sensitized
24 hours after injection and ear challenge was performed
5 days later.
Generation of dendritic cells
Dendritic cells were generated from bone marrow cells as
described (Schwarz et al., 2007). Briefly, bone marrow was
collected from tibias. Erythrocytes were lysed and the
remaining cells were passed through a nylon mesh to remove
small pieces of bone debris. The cells were washed,
resuspended, and cultured in Petri dishes at a density of
1106 cells per ml for 2 hours. Nonadherent cells were
collected and 1 106 cells per ml were placed in 24-well
plates in RPMI 1640 containing 10 ngml1 murine GM-CSF
and 1 ngml1 of murine IL-4 (both from Peprotech, Hamburg,
Germany), 5% fetal calf serum, 50 mM 2-ME, 1% nonessential
amino acids (all from PAA Laboratories, Pasching, Austria).
Two thirds of the media were replaced every 2 days and for
the last 48 hours LPS (30 ngml1; Sigma-Aldrich) was added.
Nonadherent cells were harvested on day 8. The expression
of surface molecules characteristic for adult DC (MHC class
II, CD86/B7-2) was determined in representative samples by
flow cytometry.
Coculture experiments
Dendritic cells (1106 per ml) were coupled with DNBS or
TNBS (1.0mM) for 30minutes at 37 1C, washed, and mixed
with UVR-Tregs (1106 per ml) at a ratio of 1:2. The
coculture was incubated in RPMI 1640 medium supplemen-
ted with 10% fetal calf serum and 1% essential amino acids.
After 16 hours, T cells were depleted through magnetobead
separation using a phycoerythrin-conjugated antibody direc-
ted against CD3 (PE-conjugated hamster anti-mouse CD3e;
BD Biosciences) and anti-phycoerythrin microbeads (Milte-
nyi Biotec). DCs (7 105) were injected s.c. into naive mice.
In some experiments DCs were additionally coupled with
TNBS or DNBS after coculture and were injected s.c.
FACS analysis
Purity of the CD4þCD25þ cells and of the DCs was
evaluated by flow cytometry (FC 500 CXP; Beckman Coulter,
Krefeld, Germany) using an allophycocyanin-conjugated
anti-mouse CD4 antibody (BD Biosciences), PE-labeled
anti-CD25 antibody (Miltenyi Biotec) for T cells or anti-
MHC class II PE-conjugated antibody for DC (BD
Biosciences). To prove the purity of DCs isolated after the
co-incubation with UVR-Treg, we stained DCs with an
antibody against CD3e. For the expression of CD86 (B7-2),
a rat anti-mouse antibody (Beckman Coulter) and as a
secondary antibody FITC-labeled goat anti-rat IgG (Santa
Cruz Biotechnology, Heidelberg, Germany) were used. The
expression of B7-H3 and B7-H4 was determined using biotin-
labeled anti-mouse B7-H3 and B7-H4 antibodies (NatuTec,
Frankfurt, Germany) and as second step streptavidin–allophy-
cocyanin were used (Beckman Coulter).
Statistical analysis
Data were analyzed by Student’s t-test and differences were
considered significant at Po0.05.
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